Back to Depression And Anxiety

NCT05273996

NCT05273996
Active, Not Recruiting Phase 4

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with major depression, either as a single episode or as something that has come back more than once.
  • You are able to read and write in English.
  • You scored above 25 on a standard memory and thinking test called the Mini-Mental State Examination (confirm with trial site).

Who may not be able to join:

  • You have ever had a serious dependence on alcohol or drugs at any point in your life.
  • You have a condition that affects the brain, such as fluid on the brain, brain tumors (whether cancerous or not), epilepsy, Parkinson's disease, Huntington's disease, dementia, or diseases that damage the protective covering of nerves (confirm with trial site for other similar conditions).
  • You have an untreated hormone or gland disorder, unless it is diabetes.
  • You have a confirmed diagnosis of dementia.
  • You have another main mental health condition, such as panic disorder, social phobia, obsessive-compulsive disorder (OCD), schizoaffective disorder, schizophrenia, or bipolar disorder.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 4: approximately Approved of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Active, Not Recruiting
Phase
Phase 4
Sponsor
David Steffens
Registry
clinicaltrials_gov
Start date
28 September 2021
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Montgomery-Asberg Depression Rating Scale (MADRAS); Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Neuropsychological Battery Total Score; Cognitive clinical diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov